Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
Clinical trial NCT06026514 · COMPLETED
Trial details
- NCT number
- NCT06026514
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2025-01-16
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.